✦ LIBER ✦

Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography

✍ Scribed by David J. Brooks

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 312 KB
Volume: 24
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.22581

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Although Parkinson's disease with later dementia (PDD) and dementia with Lewy bodies (DLB) are pathologically characterized by the presence of intraneuronal Lewy inclusion bodies, amyloid deposition is also associated to varying degrees with both these disorders. Fibrillar amyloid load can now be quantitated in vivo with positron emission tomography (PET) using imaging biomarkers. Here the reported findings of ^11^C‐PIB PET studies concerning the amyloid load associated with PD and its influence on dementia are reviewed. It is concluded that the presence of amyloid acts to accelerate the dementia process in Lewy body disorders, though has little influence on its nature. Anti‐amyloid strategies could be a relevant approach for slowing dementia in a number of DLB and PDD cases. © 2009 Movement Disorder Society

📜 SIMILAR VOLUMES

Treatment of dementia with Lewy bodies a

Treatment of dementia with Lewy bodies and Parkinson's disease dementia

✍ Werner Poewe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Cognitive decline and dementia affect approximately 30% to 40% of patients with idiopathic Parkinson's disease during the course of their illness. PD-dementia (PDD) and dementia with Lewy bodies (DLB) are second to Alzheimer's disease in causing degenerative dementia in the elderly. The nosological

Current treatment of dementia with Lewy

Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease

✍ David J. Burn; Ian G. McKeith 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Dementia in Parkinson's disease (PDD) is a frequent and distressing complication with major consequences. Clinical and pathological features closely link PDD and dementia with Lewy bodies (DLB), suggesting they represent part of the same disease spectrum. Although dopaminergic deficiency primarily d

Comparison of dementia with Lewy bodies

Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia

✍ Enrique Noe; Karen Marder; Karen L. Bell; Diane M. Jacobs; Jennifer J. Manly; Ya 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Abstract We compared the clinical and neuropsychological pattern of dementia with Lewy bodies (DLB) to Alzheimer's disease (AD) and Parkinson's disease with dementia (PD‐d). Sixteen patients clinically diagnosed with DLB were compared with two groups of patients with PD‐d (n = 15) and AD (n = 16

Cholinergic and other neurotransmitter m

Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies

✍ Paul T. Francis; Elaine K. Perry 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

It is now 30 years since the beginning of intensive efforts to understand the neurotransmitter biochemistry of dementia as exemplified by Alzheimer's disease and such studies have led to the development of rational treatment strategies, which are continuing to benefit patients. However, as studies b

Pentagon drawing and neuropsychological

Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia

✍ Francesca Cormack; Dag Aarsland; Clive Ballard; Martin J. Tovée 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## Objectives Early and accurate diagnosis of Dementia with Lewy Bodies (DLB) to allow the appropriate clinical treatment is a priority, given reports of severe neuroleptic sensitivity and a preferential response to cholinesterase inhibitors in these patients. There have been suggestio

Parkinson's disease and dementia with Le

Parkinson's disease and dementia with Lewy bodies: One disease or two?

✍ Irene Hegeman Richard; Michelle Papka; Ana Rubio; Roger Kurlan 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

Parkinson's disease (PD) and dementia with Lewy bodies (DLB) have clinical features in common and are both characterized neuropathologically by the presence of Lewy bodies (LBs). We conducted a clinicopathological correlation pilot study to better understand whether PD and DLB represent two distinct